Axsome Therapeutics, Inc. (AXSM) Balance Sheet Quarterly

Axsome Therapeutics, Inc.

AXSM (NASDAQ)

(%)

Financials
Axsome Therapeutics, Inc. Balance Sheet Statement Quarterly

Annual Quarterly

* (except for per share items) of USD

Period Ending:	2025 (Q4) 12-31	2025 (Q3) 09-30	2025 (Q2) 06-30	2025 (Q1) 03-31	2024 (Q4) 12-31	2024 (Q3) 09-30	2024 (Q2) 06-30
Report Filing:	2026-02-23	2025-11-03	2025-08-04	2025-05-05	2025-02-18	2024-11-12	1234
Total Current Assets	589	565.3	536.6	494.6	485.1	479.1	1234
Cash and Short Term Investments	322.9	325.3	303	300.9	315.4	327.3	1234
Cash & Equivalents	322.9	325.3	303	300.9	315.4	327.3	1234
Short Term Investments	0	0	0	0	0	0	1234
Receivables	224.5	196.5	198.8	161.4	142	124.1	1234
Inventory	27.94	23.77	18.44	16.32	15.73	14.27	1234
Other Current Assets	13.65	19.79	16.34	16.01	11.98	13.41	1234
Total Assets	689.8	669.2	639.8	596.7	568.5	561.5	1234
Total Non-Current Assets	100.8	103.9	103.2	102	83.43	82.34	1234
Property, Plant and Equipment	20.86	26.65	23.14	24.07	5.97	5.73	1234
Goodwill and Intangible Assets	52.56	54.17	55.77	57.36	58.94	60.54	1234
Goodwill	12.04	12.04	12.04	12.04	12.04	12.04	1234
Intangible Assets	40.52	42.13	43.73	45.32	46.89	48.5	1234
Long Term Investments	0	0	0	0	0	0	1234
Deferred Tax Assets	0	0	0	0	0	0	1234
Other Long Term Assets	27.4	23.09	24.25	20.61	18.53	16.07	1234
Total Current Liabilities	378.8	360.3	342.1	243.9	230.1	196.2	1234
Accounts Payable	65.54	54.23	91.63	85.66	72	64.25	1234
Notes Payable/Short Term Debt	72.98	73.23	72.35	2.27	3.26	2.91	1234
Tax Payables	0	0	0	0.96	0.96	0.493	1234
Deferred Revenue	0	0	0	0	0	0	1234
Other Current Liabilities	240.3	232.8	178.1	155	153.9	128.5	1234
Total Liabilities	601.5	595.5	566.7	543.5	511.5	468.6	1234
Total Non-Current Liabilities	222.7	235.2	224.6	299.6	281.4	272.4	1234
Total Long Term Debt	168.3	145.4	145	209	189.7	189.4	1234
Deferred Tax Liabilities Non-Current	0	0	0	0	0	0	1234
Deferred Revenue Non-Current	0	0	0	0	0	0	1234
Capital Lease Obligations	27.39	27.72	29.77	29.86	12.24	12.3	1234
Other Long Term Liabilities	26.97	62.15	49.89	60.73	79.44	70.68	1234
Total Equity	88.3	73.73	73.08	53.2	57.02	92.9	1234
Non-Controlling Interest	0	0	0	0	0	0	1234
Total Stockholders' Equity	88.3	73.73	73.08	53.2	57.02	92.9	1234
Retained Earnings	-1,306	-1,277	-1,230	-1,182	-1,123	-1,048	1234
Accumulated Other Earnings	0	0	0	0	0	0	1234
Common Stock	0.005	0.005	0.005	0.005	0.005	0.005	1234
Preferred Stock	0	0	0	0	0	0	1234
Additional Paid in Capital	1,394	1,351	1,303	1,235	1,180	1,141	1234
Total Liabilities & Total Equity	689.8	669.2	639.8	596.7	568.5	561.5	1234
Total Liabilities & Shareholders' Equity	689.8	669.2	639.8	596.7	568.5	561.5	1234
Total Investments	0	0	0	0	0	0	1234
Total Debt	241.3	218.6	217.3	211.2	193	192.3	1234
Net Debt	-81.64	-106.7	-85.71	-89.68	-122.4	-135	1234

Market is Open

After-Hours Quote

Market is Open

After-Hours Quote

Axsome Therapeutics, Inc. Balance Sheet Statement Quarterly